This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
The primary objective of this project is to explore the rise of molecular technologies in cancer screening and monitoring and their impacts on the experience of cancer survivorship. I will draw on both primary and secondary data to accomplish this objective, including:
- A scan of the published literature
- An analysis of prior qualitative interviews conducted with cancer survivors
- Expert interviews with officials in Geneva (policy makers and researchers) who are interested in discussing the rise of molecular technologies in monitoring disease status.
In this application I am applying for ethics approval for component 3 of the study (expert interviews) as I have a current ethics approval to cover component 2 of the study. The primary research method will be expert interviews conducted with approximately 5 experts interested in dicussing the rise of molecular technologies. These will be analysed using ethnographic content analysis techniques.
The TREAD Code of Practice requires that members respect the intellectual property rights of the Research Application donors and read and engage with the materials only. The Research Applications are protected by intellectual property laws and treaties around the world. All such rights are reserved. The materials in the Research Applications may not be reproduced in any format without written permission from the donors. If you would like to seek such permission, please contact tread@tghn.org. To access the resources for this application, please click on the files under the 'Useful Resources' heading.